Literature DB >> 32486340

Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps.

Dennis Paul1, Paul Maggi2, Fabio Del Piero3, Steven D Scahill1, Kelly Jean Sherman1, Samantha Edenfield1, Harry J Gould4.   

Abstract

Abstract: Concurrent activation of voltage-gated sodium channels (VGSCs) and blockade of Na+ pumps causes a targeted osmotic lysis (TOL) of carcinomas that over-express the VGSCs. Unfortunately, electrical current bypasses tumors or tumor sections because of the variable resistance of the extracellular microenvironment. This study assesses pulsed magnetic fields (PMFs) as a potential source for activating VGSCs to initiate TOL in vitro and in vivo as PMFs are unaffected by nonconductive tissues. In vitro, PMFs (0-80 mT, 10 msec pulses, 15 pps for 10 min) combined with digoxin-lysed (500 nM) MDA-MB-231 breast cancer cells stimulus-dependently. Untreated, stimulation-only, and digoxin-only control cells did not lyse. MCF-10a normal breast cells were also unaffected. MDA-MB-231 cells did not lyse in a Na+-free buffer. In vivo, 30 min of PMF stimulation of MDA-MB-231 xenografts in J/Nu mice or 4T1 homografts in BALB/c mice, concurrently treated with 7 mg/kg digoxin reduced tumor size by 60-100%. Kidney, spleen, skin and muscle from these animals were unaffected. Stimulation-only and digoxin-only controls were similar to untreated tumors. BALB/C mice with 4T1 homografts survived significantly longer than mice in the three control groups. The data presented is evidence that the PMFs to activate VGSCs in TOL provide sufficient energy to lyse highly malignant cells in vitro and to reduce tumor growth of highly malignant grafts and improve host survival in vivo, thus supporting targeted osmotic lysis of cancer as a possible method for treating late-stage carcinomas without compromising noncancerous tissues.

Entities:  

Keywords:  Na+, K+-ATPase; advanced stage carcinoma; pulsed magnetic fields; sodium channels; sodium pumps; targeted osmotic lysis

Year:  2020        PMID: 32486340     DOI: 10.3390/cancers12061420

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  3 in total

Review 1.  Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies.

Authors:  Harry J Gould; Dennis Paul
Journal:  Biomedicines       Date:  2022-04-02

2.  The Role of Targeted Osmotic Lysis in the Treatment of Advanced Carcinoma in Companion Animals: A Case Series.

Authors:  Harry J Gould; Samantha Edenfield; Paige R Miller; Kelly Jean Sherman; Brian Melius; Alissa Whitney; Robert P Hunter; Fabio Del Piero; Dennis Tracey; Dennis Paul
Journal:  Case Rep Vet Med       Date:  2022-08-02

Review 3.  Cancer as a Channelopathy-Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments.

Authors:  Harry J Gould; Dennis Paul
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.